Aaron Wealth Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Aaron Wealth Advisors's ALNY Position: Q3 2026 in Review
Aaron Wealth Advisors increased its Alnylam Pharmaceuticals (ALNY) stake by 18% in Q3 2026, buying an estimated $53.7K and bringing the position to 1,364 shares worth $337K. The position accounts for 0.02% of the portfolio, ranked #545.
Aaron Wealth Advisors first reported a position in ALNY in Q3 2025 and has held it in 5 quarters since. The position peaked at $506K in Q3 2025. 730 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Aaron Wealth Advisors held 1,364 shares of Alnylam Pharmaceuticals worth $337K as of Q3 2026.
- Aaron Wealth Advisors bought 211 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $53.7K.
- Alnylam Pharmaceuticals made up 0.02% of Aaron Wealth Advisors's portfolio in Q3 2026, its #545 holding.
- Aaron Wealth Advisors first reported a position in Alnylam Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Aaron Wealth Advisors's Alnylam Pharmaceuticals position peaked at $506K in Q3 2025.
- 730 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Aaron Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.